Current Report Filing (8-k)
October 12 2016 - 2:42PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 11, 2016
IMMUDYNE,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
333-184487
|
|
76-0238453
|
(State
or other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
50
Spring Meadow Rd.
Mount
Kisco, NY
|
|
10549
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(914) 244-1777
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
2.02. Results of Operations and Financial Condition.
On
October 11, 2016, Immudyne, Inc. (the “Company”) issued a press release announcing the Company’s preliminary
financial results for the period ended September 30, 2016, a copy of which is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
The
information in this Item 2.02 of this Form 8-K shall not be deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item
7.01. Regulation FD Disclosure
On
October 12, 2016, the Company released a new corporate presentation. Attached hereto as Exhibit 99.2 and made part of this report,
is a copy of this presentation.
Pursuant
to General Instruction B.2. to Form 8-K, the information set forth in this Item 7.01 and Exhibit 99.2 shall not be deemed “filed”
for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, or incorporated by reference
in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such
a filing.
Item
9.01. Financial Statements and Exhibits
(d)
|
Exhibits
|
|
|
99.1
|
Press Release of Immudyne, Inc., dated October 11,
2016, with respect to the Company’s preliminary financial results for period ended September 30, 2016 (furnished only).
|
|
|
99.2
|
Immudyne, Inc. corporate presentation Q4 2016 (furnished
only)
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
IMMUDYNE
INC.
|
|
(Registrant)
|
|
|
Date:
October 12, 2016
|
By:
|
/s/
Mark McLaughlin
|
|
Name:
|
Mark
McLaughlin
|
|
Title:
|
Chief
Executive Officer
|
3